Back to Search Start Over

Factors Associated with COVID-19 Vaccination Promptness after Eligibility in a North Carolina Longitudinal Cohort Study.

Authors :
Neighbors CE
Faldowski RA
Pieper CF
Taylor J
Gaines M
Sloane R
Wixted D
Woods CW
Newby LK
Source :
Vaccines [Vaccines (Basel)] 2023 Oct 26; Vol. 11 (11). Date of Electronic Publication: 2023 Oct 26.
Publication Year :
2023

Abstract

Many studies identified factors associated with vaccination intention and hesitancy, but factors associated with vaccination promptness and the effect of vaccination intention on vaccination promptness are unknown. This study identified factors associated with COVID-19 vaccination promptness and evaluated the role of vaccination intention on vaccination promptness in 1223 participants in a community-based longitudinal cohort study (June 2020 to December 2021). Participants answered questions regarding COVID-19 vaccination intention, vaccination status, and reasons for not receiving a vaccine. The association of baseline vaccine hesitancy with vaccination was assessed by the Kaplan-Meier survival analysis. Follow-up analyses tested the importance of other variables predicting vaccination using the Cox proportional hazards model. Older age was associated with shorter time to vaccination (HR = 1.76 [1.37-2.25] 85-year-old versus 65-year-old). Lower education levels (HR = 0.80 [0.69-0.92]), household incomes (HR = 0.84 [0.72-0.98]), and baseline vaccination intention of 'No' (HR = 0.16 [0.11-0.23]) were associated with longer times to vaccination. The most common reasons for not being vaccinated (N = 58) were vaccine safety concerns (n = 33), side effects (n = 28), and vaccine effectiveness (n = 25). Vaccination campaigns that target populations prone to hesitancy and address vaccine safety and effectiveness could be helpful in future vaccination rollouts.

Details

Language :
English
ISSN :
2076-393X
Volume :
11
Issue :
11
Database :
MEDLINE
Journal :
Vaccines
Publication Type :
Academic Journal
Accession number :
38005971
Full Text :
https://doi.org/10.3390/vaccines11111639